ANIX
Anixa Biosciences Inc (ANIX
NASDAQ · Healthcare · Biotechnology · US
$2.77
+0.36%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 6.65x
- Price / sales
- —
- Price / cash flow
- -13.06x
Enterprise value
- Enterprise value
- $81.3M
- EV / sales
- —
- EV / EBITDA
- -7.70x
- EV / EBIT
- -7.41x
- Market cap
- $96.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jul 1, 2026